Peter Lomedico

About

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund accelerating life-changing solutions to treat, prevent, and cure type 1 diabetes (T1D) through catalytic commercial investments. Through its investments in partnership with private capital, including venture capital, corporations and foundations, the T1D Fund seeks to attract the private investment necessary to advance drugs, devices, diagnostics, and vaccines into the hands of those living with T1D. The T1D Fund invests in areas strategically aligned with JDRF, the leading global organization funding T1D research, with an exclusive focus on supporting the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission. Before joining the T1D Fund in 2017, Peter Lomedico spent 11 years working with JDRF Research to establish T1D research collaborations with biotechnology and pharmaceutical companies. Peter has a diverse background in molecular biology, diabetes r

Investment Focus

Location

Boston, US